Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Genes, Chromosomes & Cancer|March 1, 1997
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics ConsortiumP Devilee, J Hermans, J Eyfjörd, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2013
Long term improved quality of life by a 2-week group physical and educational intervention shortly after breast cancer chemotherapy completion. Results of the 'Programme of Accompanying women after breast Cancer treatment completion in Thermal resorts' (PACThe) randomised clinical trial of 251 patientsF Kwiatkowski, M A Mouret-Reynier, M Duclos, et al.
International Journal of Cancer|December 10, 2015
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancerJ M Nabholtz, N Chalabi, N Radosevic-Robin, et al.
British Journal of Cancer|June 9, 1999
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics ConsortiumV Launonen, K Laake, P Huusko, et al.
Cancer Research|March 21, 1998
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parametersC M Phelan, A Borg, M Cuny, et al.
Human Molecular Genetics|December 26, 2001
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesisM Esteller, M F Fraga, M Guo, et al.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
Cancer Genomics & Proteomics|January 9, 2009
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differencesN Chalabi, D J Bernard-Gallon, Y J Bignon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2S R Lakhani, B A Gusterson, J Jacquemier, et al.
Journal of the National Cancer Institute|August 13, 1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutationsS R Lakhani, J Jacquemier, J P Sloane, et al.
Pageof 29